CID 10458325

Tesevatinib

Structural Information

Molecular Formula
C24H25Cl2FN4O2
SMILES
CN1C[C@H]2CC(C[C@H]2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC
InChI
InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13?,14-,15+
InChIKey
HVXKQKFEHMGHSL-GOOCMWNKSA-N
Compound name
7-[[(3aR,6aS)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

16
References

2432
Patents

490.13385 Da
Monoisotopic Mass

5.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 491.14113 213.9
[M+Na]+ 513.12307 227.9
[M+NH4]+ 508.16767 221.0
[M+K]+ 529.09701 222.1
[M-H]- 489.12657 218.0
[M+Na-2H]- 511.10852 217.9
[M]+ 490.13330 217.5
[M]- 490.13440 217.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe